Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant colocalization of eotaxin mRNA to bronchial epithelial and endothelial cells

被引:362
作者
Ying, S
Robinson, DS
Meng, Q
Rottman, J
Kennedy, R
Ringler, DJ
Mackay, CR
Daugherty, BL
Springer, MS
Durham, SR
Williams, TJ
Kay, AB
机构
[1] Imperial Coll Sch Med, Natl Heart & Lung Inst, London SW3 6LY, England
[2] Leukosite Inc, Cambridge, MA USA
[3] Merck Res Labs, Rahway, NJ USA
[4] Imperial Coll Sch Med, Upper Resp Med Natl Heart & Lung Inst, London, England
基金
英国惠康基金;
关键词
eotaxin; CCR3; asthma;
D O I
10.1002/eji.1830271252
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Eotaxin is a newly discovered C-C chemokine which preferentially attracts and activates eosinophil leukocytes by acting specifically on its receptor CCR3. The airway inflammation characteristic of asthma is believed to be, at least in part, the result of eosinophil-dependent tissue injury. This study was designed to determine whether there is increased expression of eotaxin and CCR3 in the bronchial mucosa of asthmatics and whether this is associated with disease severity. The major sources of eotaxin and CCR3 mRNA were determined by colocalization experiments. Bronchial mucosal biopsy samples were obtained from atopic asthmatics and normal non-atopic controls. Eotaxin and CCR3 mRNA were identified in tissue sections by in situ hybridization (ISH) using radiolabeled riboprobes and their protein product visualized by immunohistochemistry (IHC). Co-localization experiments were performed by double ISH/IHC. Eotaxin and CCR3 (mRNA and protein) were significantly elevated in atopic asthmatics compared with normal controls. In the asthmatics there was a highly significant inverse correlation between eotaxin mRNA(+) cells and the histamine provocative concentration causing a 20% fall in FEV1 (PC20). Cytokeratin-positive epithelial cells and CD31(+) endothelial cells were the major source of eotaxin mRNA whereas CCR3 colocalized predominantly to eosinophils. These data are consistent with the hypothesis that damage to the bronchial mucosa in asthma involves secretion of eotaxin by epithelial and endothelial cells resulting in eosinophil infiltration mediated via CCR3. Since selective (eotaxin) and non-selective C-C chemokines such as RANTES, MCP-3 and MCP-4 all stimulate eosinophils via CCR3, this receptor is potentially a prime therapeutic target in the spectrum of diseases involving eosinophil-mediated tissue damage.
引用
收藏
页码:3507 / 3516
页数:10
相关论文
共 42 条
[1]   CC-CHEMOKINES IN ALLERGIC INFLAMMATION [J].
BAGGIOLINI, M ;
DAHINDEN, CA .
IMMUNOLOGY TODAY, 1994, 15 (03) :127-133
[2]   EOSINOPHILIC INFLAMMATION IN ASTHMA [J].
BOUSQUET, J ;
CHANEZ, P ;
LACOSTE, JY ;
BARNEON, G ;
GHAVANIAN, N ;
ENANDER, I ;
VENGE, P ;
AHLSTEDT, S ;
SIMONYLAFONTAINE, J ;
GODARD, P ;
MICHEL, FB .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1033-1039
[3]   EOSINOPHILS, T-LYMPHOCYTES, MAST-CELLS, NEUTROPHILS, AND MACROPHAGES IN BRONCHIAL BIOPSY SPECIMENS FROM ATOPIC SUBJECTS WITH ASTHMA - COMPARISON WITH BIOPSY SPECIMENS FROM ATOPIC SUBJECTS WITHOUT ASTHMA AND NORMAL CONTROL SUBJECTS AND RELATIONSHIP TO BRONCHIAL HYPERRESPONSIVENESS [J].
BRADLEY, BL ;
AZZAWI, M ;
JACOBSON, M ;
ASSOUFI, B ;
COLLINS, JV ;
IRANI, AMA ;
SCHWARTZ, LB ;
DURHAM, SR ;
JEFFERY, PK ;
KAY, AB .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1991, 88 (04) :661-674
[4]   COOPERATION BETWEEN INTERLEUKIN-5 AND THE CHEMOKINE EOTAXIN TO INDUCE EOSINOPHIL ACCUMULATION IN-VIVO [J].
COLLINS, PD ;
MARLEAU, S ;
GRIFFITHSJOHNSON, DA ;
JOSE, PJ ;
WILLIAMS, TJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (04) :1169-1174
[5]   T-CELLS AND EOSINOPHILS IN THE PATHOGENESIS OF ASTHMA [J].
CORRIGAN, CJ ;
KAY, AB .
IMMUNOLOGY TODAY, 1992, 13 (12) :501-507
[6]   MONOCYTE CHEMOTACTIC PROTEIN-3 IS A MOST EFFECTIVE BASOPHIL-ACTIVATING AND EOSINOPHIL-ACTIVATING CHEMOKINE [J].
DAHINDEN, CA ;
GEISER, T ;
BRUNNER, T ;
VONTSCHARNER, V ;
CAPUT, D ;
FERRARA, P ;
MINTY, A ;
BAGGIOLINI, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :751-756
[7]   Cloning, expression, and characterization of the human eosinophil eotaxin receptor [J].
Daugherty, BL ;
Siciliano, SJ ;
DeMartino, JA ;
Malkowitz, L ;
Sirotina, A ;
Springer, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :2349-2354
[8]   Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes [J].
Forssmann, U ;
Uguccioni, M ;
Loetscher, P ;
Dahinden, CA ;
Langen, H ;
Thelen, M ;
Baggiolini, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (12) :2171-2176
[9]  
FRIGAS E, 1981, MAYO CLIN PROC, V56, P345
[10]   Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia [J].
GarciaZepeda, EA ;
Rothenberg, ME ;
Ownbey, RT ;
Celestin, J ;
Leder, P ;
Luster, AD .
NATURE MEDICINE, 1996, 2 (04) :449-456